Viswanath Archana, Oreadi Daniel, Finkelman Matthew, Klein Gustavo, Papageorge Maria
Assistant Professor and Director of Clinical Research, Department of Oral and Maxillofacial Surgery, Tufts University School of Dental Medicine, Boston, MA.
Assistant Professor, Department of Oral and Maxillofacial Surgery, Tufts University School of Dental Medicine, Boston, MA.
J Oral Maxillofac Surg. 2019 Feb;77(2):262-270. doi: 10.1016/j.joms.2018.09.010. Epub 2018 Sep 20.
Pre-emptive analgesia is known to reduce postoperative pain after third molar removal. The purpose of this study was to compare postoperative pain in patients receiving either preoperative intravenous (IV) ibuprofen or preoperative IV acetaminophen for third molar surgery.
This study was a randomized, single-blinded clinical study conducted in patients undergoing surgical extraction of 2 or more impacted third molars under deep sedation. This study compared 2 interventions: 800 mg of IV ibuprofen (Caldolor; Cumberland Pharmaceuticals, Nashville, TN) and 1,000 mg of IV acetaminophen (Ofirmev; Mallinckrodt Pharmaceuticals, Staines-upon-Thames, United Kingdom). The primary outcome variable was postoperative pain measured on a visual analog scale at different time points. The secondary outcome variable was the amount of postoperative analgesic (narcotic and over-the-counter) medication taken in both groups. The Mann-Whitney U test was used to compare groups in terms of outcomes, the χ test was used to assess associations between nominal variables, and Spearman correlations were used to assess associations between continuous variables. Significance was set at P < .05.
The study sample consisted of 58 patients (39 female and 19 male patients). A total of 41 patients (IV ibuprofen, n = 19; IV acetaminophen, n = 22) completed the study. Equal distributions of age, gender, and number of impacted teeth were noted between the groups. At 4 hours postoperatively, the pain level in the ibuprofen group was significantly lower than that in the acetaminophen group (P = .004). This trend continued at 24 hours (P = .019) and 48 hours (P = .017). The average amount of narcotic medication taken in the ibuprofen group (2.68 ± 2.26 doses) was lower than that in the acetaminophen group (7.32 ± 6.68 doses), and the result was statistically significant (P = .005).
Pre-emptive analgesia with IV ibuprofen is more effective than IV acetaminophen in reducing postoperative pain and opioid use for third molar surgery.
已知超前镇痛可减轻第三磨牙拔除术后的疼痛。本研究的目的是比较接受术前静脉注射布洛芬或术前静脉注射对乙酰氨基酚的患者在第三磨牙手术术后的疼痛情况。
本研究是一项随机、单盲临床研究,研究对象为在深度镇静下接受2颗或更多颗阻生第三磨牙手术拔除的患者。本研究比较了2种干预措施:800毫克静脉注射布洛芬(Caldolor;坎伯兰制药公司,田纳西州纳什维尔)和1000毫克静脉注射对乙酰氨基酚(Ofirmev;马林克罗特制药公司,英国泰晤士河畔斯泰恩斯)。主要结局变量是在不同时间点用视觉模拟量表测量的术后疼痛。次要结局变量是两组术后服用的镇痛药物(麻醉性和非处方药物)的量。采用曼-惠特尼U检验比较两组的结局,采用χ检验评估名义变量之间的关联,采用斯皮尔曼相关性分析评估连续变量之间的关联。显著性设定为P < 0.05。
研究样本包括58例患者(39例女性和19例男性患者)。共有41例患者(静脉注射布洛芬组,n = 19;静脉注射对乙酰氨基酚组,n = 22)完成了研究。两组之间年龄、性别和阻生牙数量分布均衡。术后4小时,布洛芬组的疼痛水平显著低于对乙酰氨基酚组(P = 0.004)。这一趋势在术后24小时(P = 0.019)和48小时(P = 0.017)持续存在。布洛芬组服用的麻醉性药物平均量(2.68 ± 2.26剂)低于对乙酰氨基酚组(7.32 ± 6.68剂),结果具有统计学显著性(P = 0.005)。
对于第三磨牙手术,术前静脉注射布洛芬进行超前镇痛在减轻术后疼痛和减少阿片类药物使用方面比静脉注射对乙酰氨基酚更有效。